iCAD
This article was originally published in The Gray Sheet
Executive Summary
Company plans to file a 510(k) for the VeraLook computer-aided detection system for computed tomography (CT) colonography late this month or in April. iCAD previewed the investigational system at the European Society of Radiology annual meeting in Vienna March 6-10. The device can automatically identify polyps and streamline the image reading process, firm says. Data from a National Cancer Institute study published last fall supports using CT colonography, a non-invasive alternative to colonoscopy, as a screening option in cancers 10 mm or larger, but use of the technology may be limited by its cost (1"The Gray Sheet" Sept. 22, 2008, p. 21)
You may also be interested in...
CT Colonoscopy Gets Further Support From NCI Study In NEJM
Results of a major study sponsored by the National Cancer Institute and the American College of Radiology Imaging Network provide more support for computed tomographic colonography as an alternative to visual colonoscopy for colorectal cancer screening
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.